DRTS vs SIBN: stock comparison and AI forecast
Alpha Tau Medical Ltd. (DRTS) and Si-Bone, Inc. (SIBN) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
DRTS Alpha Tau Medical Ltd.
- Price
- $13.30 +69.4% · 6M
- Market Cap
- $1.17B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
SIBN Si-Bone, Inc.
- Price
- $24.24 +87.2% · 6M
- Market Cap
- $1.09B
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Six-month price performance
Closing prices rebased to 100 at the start of the window.
Key facts
- DRTS and SIBN have similar market capitalizations ($1.17B and $1.09B).
- Over the last six months SIBN returned +87.2% and DRTS +69.4%.
- SIBN carries 0.39 times debt per unit of equity, against 0.37 times for DRTS.
- Both companies share the SEC industry classification Surgical & Medical Instruments & Apparatus.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | DRTS | SIBN |
|---|---|---|
| Market Cap | $1.17B | $1.09B |
| P/B Ratio | 15.18x | 5.88x |
| EPS | $-0.98 | $-0.41 |
| Book Value/Share | $0.88 | $4.12 |
| Revenue/Share | – | $4.92 |
| FCF/Share | – | $-0.09 |
Profitability & Margins
| Metric | DRTS | SIBN |
|---|---|---|
| ROE | -96.5% | -7.4% |
| ROA | -70.4% | -5.3% |
| ROIC | -82.3% | -7.4% |
| Gross Margin | – | 79.4% |
| Operating Margin | – | -7.6% |
| Net Margin | – | -6.2% |
| EBT Margin | – | -6.0% |
| Tax Rate | -0.2% | 0.0% |
Financial Health
| Metric | DRTS | SIBN |
|---|---|---|
| Current Ratio | 7.45x | 7.58x |
| Quick Ratio | – | 6.15x |
| D/E Ratio | 0.37x | 0.39x |
| Financial Leverage | 1.37x | 1.39x |
| Interest Coverage | -95.6x | -1.0x |
| Working Capital | $68M | $195M |
Cash Flow
| Metric | DRTS | SIBN |
|---|---|---|
| Operating Cash Flow | -$46M | $6M |
| Free Cash Flow | – | -$4M |
| Capital Spending | – | -$10M |
| FCF/Sales | – | -1.9% |
| CapEx/Sales | – | 4.7% |
Operational Efficiency
| Metric | DRTS | SIBN |
|---|---|---|
| Asset Turnover | – | 0.86x |
| Receivables Turnover | – | 7.0x |
| Inventory Turnover | – | 1.1x |
| Fixed Assets Turnover | – | 8.7x |
| Days Sales Outstanding | – | 52 days |
| Days Inventory | – | 340 days |
| Payables Period | – | 84 days |
| Cash Conversion Cycle | – | 308 days |
Income Statement
| Metric | DRTS | SIBN |
|---|---|---|
| Total Revenue | – | $221M |
| Operating Income | -$78M | -$17M |
| Net Income | -$74M | -$14M |
| R&D Expense | $59M | $18M |
| SG&A Expense | – | $219M |
| Cost of Goods Sold | – | $45M |
Dividend & Shareholder Information
| Metric | DRTS | SIBN |
|---|---|---|
| Shares Outstanding | 88M | 45M |
DRTS vs SIBN: stock comparison and AI forecast
Which is bigger, DRTS or SIBN?
DRTS and SIBN have similar market capitalizations ($1.17B and $1.09B).
Which stock performed better over the last six months, DRTS or SIBN?
Over the last six months SIBN returned +87.2% and DRTS +69.4%.
Which one does Intratio's AI model rank higher, DRTS or SIBN?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.